# Stefan Hantel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stefan-hantel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,827 |
| Field | Diabetes Treatment and Management |
| h-index | 34 |
| i10-index | 47 |
| OpenAlex ID | https://openalex.org/A5007480850 |
| Works | 109 |

## Researcher papers

- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME <sup>®</sup> trial](https://scholariq.org/papers/heart-failure-outcomes-with-empagliflozin-in-patients-with-type-2-diabetes-at/)
- [How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial](https://scholariq.org/papers/how-does-empagliflozin-reduce-cardiovascular-mortality-insights-from-a-mediation/)
- [Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial](https://scholariq.org/papers/effects-of-empagliflozin-on-risk-for-cardiovascular-death-and-heart-failure/)
- [Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial](https://scholariq.org/papers/empagliflozin-and-kidney-function-decline-in-patients-with-type-2-diabetes-a/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.